Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 95 B, Issue 2, 2010, Pages 475-480

  Gautam, Shalini ^a,b   Korchagina, Elena Y ^c   Bovin, Nicolai V ^c   Federspiel, William J ^a,b,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh   (United States)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

antibodies; antibody filter; fiber membranes; immunoaffinity absorption; regenerative medicine

Indexed keywords

ACTIVATION METHOD; ACTIVE SITE; ANTIBODY BINDING; ANTIGEN BINDING; BASIC MEDIUM; BINDING CAPACITIES; BLOOD GROUP; BLOOD VOLUMES; CYANOGEN BROMIDE; FIBER MEMBRANES; FIBER SURFACE; HOLLOW FIBER MEMBRANES; IMMUNOAFFINITY; NEUTRAL PH; REGENERATIVE MEDICINE; SURFACE ACTIVATION; SURFACE AREA; VOLUME RATIO; WHOLE BLOOD;

ABSORPTION; ADSORPTION; BINDING SITES; BLOOD; BROMINE COMPOUNDS; CONJUGATED POLYMERS; DIALYSIS; FIBERS; MOLECULAR WEIGHT; MONOCLONAL ANTIBODIES; REACTOR CORES; ULTRAFILTRATION;

ANTIGENS;

ANTIBODY; CYANOGEN BROMIDE; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; SODIUM HYDROXIDE; TRIETHYLAMINE; TRISACCHARIDE;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BINDING SITE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD VOLUME; CONJUGATE; DIALYSIS; GRAFT REJECTION; HOLLOW FIBER MEMBRANE; MOLECULAR WEIGHT; QUANTITATIVE ANALYSIS; REGENERATIVE MEDICINE; ULTRAFILTRATION;

ABO BLOOD-GROUP SYSTEM; ADSORPTION; ANTIBODIES; ANTIGENS; FILTRATION; MOLECULAR WEIGHT;

EID: 78649686250     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31707     Document Type: Article

References (28)

1. Squifflet JP, De Meyer M, Malaise J, Latinne D, Pirson Y, Alexandre GP,. Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. Exp Clin Transplant 2004; 2: 208-213.
2. Futagawa Y, Terasaki PI,. ABO incompatible kidney transplantation-An analysis of UNOS Registry data. Clin Transplant 2006; 20: 122-126.
3. Aladag M, Gurakar A, Camci C, Yong Y, Wright H, Nour B,. Sebastian A Compatible ABO mismatch and liver transplantation: A single center's experience. Exp Clin Transplant 2006; 4: 467-469.
4. Winters JL, Gloor JM, Pineda AA, Stegall MD, Moore SB,. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apher 2004; 19: 79-85.
5. Alkhunaizi AM, de Mattos AM, Barry JM, Bennett WM, Norman DJ,. Renal transplantation across the ABO barrier using A2 kidneys. Transplantation 1999; 67: 1319-1324.
6. Gloor JM, Lager DJ, Moore SB, Pineda AA, Fidler ME, Larson TS, Grande JP, Schwab TR, Griffin MD, Prieto M, Nyberg SL, Velosa JA, Textor SC, Platt JL, Stegall MD,. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75: 971-977.
7. Segev DL, Simpkins CE, Warren DS, King KE, Shirey RS, Maley WR, Melancon JK, Cooper M, Kozlowski T, Montgomery RA,. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5: 2570-2575.
8. Norden G, Briggs D, Cockwell P, Lipkin G, Mjornstedt L, Molne J, Ready A, Rydberg L, Samuelsson O, Svalander CT, Breimer ME,. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti- CD20 antibody treatment. Xenotransplantation 2006; 13: 148-153.
9. Tyden G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I,. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5: 145-148.
10. Rydberg L, Bengtsson A, Samuelsson O, Nilsson K, Breimer ME,. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transpl Int 2004; 17: 666-672.
11. Bouget J, Chevret S, Chastang C, Raphael JC,. Plasma exchange morbidity in Guillain-Barre syndrome: Results from the French prospective, randomized, multicenter study. The French Cooperative Group. Crit Care Med 1993; 21: 651-658.
12. Madore F,. Plasmapheresis. 2002. Technical aspects and indications. Crit Care Clin 18: 375-392.
13. Xu Y, Lorf T, Sablinski T, Gianello P, Bailin M, Monroy R, Kozlowski T, Awwad M, Cooper DKC, Sachs DH,. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1- 4betaGlc-X immunoaffinity column. Transplantation 1998; 65: 172-179.
14. Hout MS, LeJeune KE, Schaack TM, Bristow DK, Federspiel WJ,. Specific removal of anti-A and anti-B antibodies by using modified dialysis filters. ASAIO J 2000; 46: 702-706.
15. Ghosh R,. Protein separation using membrane chromatography: Opportunities and challenge. J Chromatogr A 2002; 952: 13-27.
16. Hout MS,. Selective Antibody Removal From Blood, Plasma and Buffer Using Hollow Fiber-Based Specific Antibody Filters. Pittsburgh: University of Pittsburgh; 2003.
17. Gautama S, Korchagina EY, Bovin NV, William J,. Monoclonal anti-A antibody removal by synthetic A antigen immobilized on specific antibody filters, Federspiel. Biotechnol Bioeng 2008; 99: 876-883.
18. Kohn J, Wilchek M,. Mechanism of activation of Sepharose and Sephadex by cyanogens bromide. Enzyme Microb Technol 1982; 4: 161-163.
19. Kohn J, Wilchek M,. The use of cyanogen bromide and other novel cyanylating agents for the activation of polysaccharide resins. Appl Biochem Biotechnol 1984; 9: 285-305.
20. Korchagina E, Bovina NV,. Synthesis of spaced trisaccharides with blood group A and B specificity, their fragments, and structural analogs. Bioorg Chem 1992; 18: 283-298.
21. Bovin NV, Korchagina E, Zemlyanukhina TV, Byramova NE, Galanina OE, Zemlyakov AE,. Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamides. Glycoconj J 1993; 10: 142-151.
22. Lu Y, Irani N, Grotewold E,. Covalent attachment of the plant natural product naringenin to small glass and ceramic beads. BMC Chem Biol 2005; 5: 3.
23. Solovan JC, Oh HI, Alikhani A, Gautam S, Vlasova K, Korchagina EY, Bovin NV, Federspiel WJ,. Synthetic blood groups antigens for anti-A removal device and their interaction with monoclonal anti-A IgM. Transplant Immunol 2006; 16: 245-249.
24. Beimler J, Zeier M,. ABO-incompatible transpantation-A safe way to perform renal transplantation. Nephrol Dial Transplant 2006; 1-3.
25. Shilova NV, Galanina OE, Pochechueva TV, Chinarev AA, Kadykov VA, Tuzikov AB, Bovin NV,. High molecular weight neoglycoconjugates for solid phase assays. Glycoconjugate J 2005; 22: 43-51.
26. Bovin N,. Polyacrylamide-based glycoconjugates as tools in glycobiology. Glycoconjugate J 1998; 15: 431-446.
27. Yarmush ML, Weiss AM, Antonsen KP, Odde DJ, Yarmush DM,. Immunoaffinity purification: Basic principles and operational considerations. Biotechnol Adv 1992; 10: 413-446.
28. Kohn J, Wilchek M, A new approach (cyano-transfer) for cyanogens bromide activation of Sepharose at neutral pH, which yields activated resins, free of interfering nitrogen derivatives, Biochem Biophys Res Commun 1982, 107: 3,878-884.